Navilas® retina laser- The impact of reduced injection burden on practice revenues

/ Publications / Navilas® retina laser- The impact of reduced injection burden on practice revenues

Navilas® retina laser- The impact of reduced injection burden on practice revenues

Authors: Dr. Jacob Menzler
Presented: October 1, 2019
Type: Clinical stories
In this short video interview, Dr. Jacob Menzler explains a study comparing anti-VEGF monotherapy with the use of Navilas® and a reduced injection number.
Share
Share

Related publications and webinars

From Minimally Invasive Procedure to Photocoagulation: Personalized retinal care with Navilas® (Japanese)

  • Type:
  • Presented:February 8, 2024
Priv.-Doz. Dr. med. Yoko Miura

On-Demand Webinar: Navilas in der täglichen Praxis

  • Type:
  • Presented:February 1, 2017
Dr. Bernd Fassebender
  • The treatment strategy and selected parameters presented in content listed here are solely the responsibility of the treating ophthalmologist, who is required to be familiar with the most recent literature/guidelines or recommendations, as well as with the usage of the Navilas Laser System according to the current Operator’s Manual.